Pfizer Ltd. — Board/Management Information 2023

Oct 28, 2023

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901,

Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

October 28, 2023

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure − Requirements) Regulations, 2015 Appointment of Mr. P. Rengan as Executive Director – Plant Operations.

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today appointed Mr. P. Rengan (DIN: 10362899) as an Additional Director of the Company, designated as Executive Director – Plant Operations, for a period of 5 years with effect from October 28, 2023. The appointment of Mr. Rengan will be subject to the approval of shareholders through Postal Ballot.

Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 and List/Comp/14/2018-19 dated June 20, 2018, are enclosed as Annexure A.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2023.10.28 15:17:07 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

Encl: A/a

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in

ANNEXURE A

Additional details of Mr. P Rengan

Sr.no.1. 2. 3.	Particulars	Particulars	Details	Details	Details
	Reasons for change		Fresh Appointment
	Date of Appointment and Term		5 (Five) years effective October 28, 2023
	AffirmationasperList/Comp/14/2018-19 dated June20, 2018		We hereby affirm that Mr. P Rengan is not debarredor disqualified from holding the office of Director byvirtue of any order from MCA/SEBI or any other suchstatutory authority.
4. 5. 6.			statutory authority.
	RelaKey	tionshipInter-seDirectors/Managerial Personnel	Mr. P Rengan is not related toDirectors/Key Managerial Personnel	any of t	he
	NumCom	ber of Shares held in thepany	NIL
	Brief	Profile	Mr. P Rengan is a Pharmaceutical Prover 20 years of experience in site omanufacturing & packaging operatioSenior Director – Plant OperationsManufacturing facility at Goa.Mr. Rengan is a Master of TPharmaceutical Operations & ManBirla Institute of Technology & ScienceofBusinessAdministrationfroUniversity and a Bachelor of PhDr. M.G.R. Medical University.Mr. Rengan joined the Company’ssite at Goa in 2004. During his teCompany, Mr. Rengan has held severincreasing responsibility across afunctions,includingProduction;Health & Safety; and Operational ExceMr. P Rengan was awarded with th	ofessional wiperations anns and is tof Companyechnologyagement fro, Pilani, MastmAnnamalarmacy froManufacturinure with thal positionsnumberEnvironmenllence.e Global Be
			Practice Award by Wyeth LLC for dimlementin the Skill-Will Com	eveloping anetenc-bas
			pgTraining system for critical manufactu	pyring operatio